中红医疗
(300981)
| 流通市值：53.14亿 | | | 总市值：57.98亿 |
| 流通股本：3.93亿 | | | 总股本：4.29亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 802,308,968.19 | 839,547,885.27 | 935,957,295.81 | 597,585,652.51 |
| 交易性金融资产 | 1,839,343,581.09 | 1,748,824,447.61 | 1,757,064,730.74 | 1,727,471,564.54 |
| 衍生金融资产 | 0 | 0 | - | 0 |
| 应收票据及应收账款 | 486,749,881.8 | 491,526,455.04 | 464,867,630.5 | 430,266,815.3 |
| 其中：应收票据 | 974,887.19 | 1,795,609.32 | 3,187,725.22 | 2,789,352.84 |
| 应收账款 | 485,774,994.61 | 489,730,845.72 | 461,679,905.28 | 427,477,462.46 |
| 应收款项融资 | 2,276,060.17 | 629,128.49 | 1,380,894.87 | 1,024,680.31 |
| 预付款项 | 92,556,323.8 | 92,443,300.26 | 83,379,055.14 | 48,118,631.65 |
| 其他应收款合计 | 27,304,549.55 | 29,308,311.45 | 27,337,208.86 | 31,820,374.6 |
| 存货 | 559,322,721.39 | 627,275,073.39 | 682,505,295.92 | 576,387,552.98 |
| 合同资产 | - | 0 | - | 0 |
| 一年内到期的非流动资产 | - | 0 | 0 | 157,464,000 |
| 其他流动资产 | 1,048,979,065.03 | 1,177,915,284.27 | 858,085,292.61 | 999,796,013.39 |
| 流动资产合计 | 4,858,841,151.02 | 5,007,469,885.78 | 4,810,577,404.45 | 4,569,935,285.28 |
| 非流动资产: | | | | |
| 债权投资 | 14,816,112.59 | 14,513,047.65 | 14,973,661.09 | 14,737,886.45 |
| 其他债权投资 | 0 | 0 | - | 0 |
| 长期应收款 | 0 | 0 | - | 0 |
| 长期股权投资 | 33,466,374.49 | 33,039,650.47 | 32,490,105.04 | 32,976,617.91 |
| 其他权益工具投资 | 94,469,071.54 | 94,091,153.1 | 94,307,529.41 | 94,016,691.95 |
| 其他非流动金融资产 | 145,167,709 | 145,167,709 | 139,167,709 | 139,167,709 |
| 投资性房地产 | 0 | 0 | - | 0 |
| 固定资产 | 1,779,021,598.98 | 1,709,381,099.75 | 1,750,114,317.69 | 1,807,880,707.08 |
| 在建工程 | 152,661,985.87 | 113,583,160.99 | 97,936,759.92 | 84,090,530.68 |
| 生产性生物资产 | 0 | 0 | - | 0 |
| 油气资产 | 0 | 0 | - | 0 |
| 使用权资产 | 15,794,096.69 | 17,568,332.45 | 19,570,002.22 | 13,753,874.31 |
| 无形资产 | 146,319,294.61 | 147,317,336.38 | 150,342,823.76 | 153,560,449.39 |
| 开发支出 | 0 | 0 | 233,207.58 | 0 |
| 商誉 | 153,880,890.26 | 149,441,548.15 | 149,441,548.15 | 149,441,548.15 |
| 长期待摊费用 | 3,011,996.85 | 3,299,366.67 | 3,586,736.5 | 3,624,518.87 |
| 递延所得税资产 | 58,918,586.3 | 58,775,147 | 58,151,721.04 | 58,902,258.96 |
| 其他非流动资产 | 195,710,428.82 | 112,328,896.01 | 108,686,200.58 | 108,272,718.5 |
| 非流动资产合计 | 2,793,238,146 | 2,598,506,447.62 | 2,619,002,321.98 | 2,660,425,511.25 |
| 资产总计 | 7,652,079,297.02 | 7,605,976,333.4 | 7,429,579,726.43 | 7,230,360,796.53 |
| 流动负债: | | | | |
| 短期借款 | 842,421,511.72 | 862,355,485.91 | 484,780,817.18 | 391,527,277.31 |
| 交易性金融负债 | 7,688,017.08 | 7,688,017.08 | 15,615,487.6 | 16,082,792.4 |
| 衍生金融负债 | 0 | 0 | - | 0 |
| 应付票据及应付账款 | 425,838,379.18 | 544,361,495.71 | 591,123,294.58 | 486,538,125.8 |
| 其中：应付票据 | 160,542,625.01 | 254,483,575.37 | 318,247,518.96 | 233,884,319.01 |
| 应付账款 | 265,295,754.17 | 289,877,920.34 | 272,875,775.62 | 252,653,806.79 |
| 合同负债 | 64,660,767.94 | 69,849,082.87 | 74,622,790.93 | 73,797,742.86 |
| 应付职工薪酬 | 63,118,271.91 | 67,526,338.36 | 64,601,968.37 | 69,772,426.12 |
| 应交税费 | 6,159,788.11 | 5,412,006.86 | 6,604,191.87 | 13,070,467.19 |
| 其他应付款合计 | 13,827,372.7 | 14,467,591.37 | 14,109,326.11 | 28,093,052.42 |
| 其中:应付利息 | - | 0 | 0 | 0 |
| 应付股利 | - | 0 | - | 0 |
| 一年内到期的非流动负债 | 106,091,462.16 | 98,846,861.08 | 68,954,115.56 | 148,666,729.22 |
| 其他流动负债 | 2,588,264.54 | 4,149,874.21 | 4,594,789.35 | 8,880,799.8 |
| 流动负债合计 | 1,532,393,835.34 | 1,674,656,753.45 | 1,325,006,781.55 | 1,236,429,413.12 |
| 非流动负债: | | | | |
| 长期借款 | 561,349,847.14 | 359,431,000 | 416,975,400 | 330,213,742.94 |
| 应付债券 | 0 | 0 | - | 0 |
| 优先股 | 0 | 0 | - | 0 |
| 永续债 | 0 | 0 | - | 0 |
| 租赁负债 | 16,245,097.12 | 14,285,677.19 | 14,707,189.79 | 8,573,902.35 |
| 递延收益 | 19,586,956.48 | 20,470,703.71 | 21,432,066.33 | 20,894,673.68 |
| 递延所得税负债 | 14,165,283.92 | 12,685,746.12 | 11,679,224.68 | 13,563,464.52 |
| 非流动负债合计 | 611,347,184.66 | 406,873,127.02 | 464,793,880.8 | 373,245,783.49 |
| 负债合计 | 2,143,741,020 | 2,081,529,880.47 | 1,789,800,662.35 | 1,609,675,196.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 428,864,959 | 428,864,959 | 390,007,800 | 390,007,800 |
| 其他权益工具 | 0 | 0 | - | 0 |
| 优先股 | 0 | 0 | - | 0 |
| 永续债 | 0 | 0 | - | 0 |
| 资本公积 | 1,676,986,587.94 | 1,676,986,587.94 | 1,715,843,746.94 | 1,715,843,746.94 |
| 减:库存股 | 18,985,800.89 | 18,985,800.89 | 18,985,800.89 | 18,985,800.89 |
| 其他综合收益 | 3,855,674.31 | 4,255,091.04 | 4,637,380.49 | 4,891,077.57 |
| 专项储备 | 0 | 0 | - | 0 |
| 盈余公积 | 95,661,783.43 | 95,661,783.43 | 95,661,783.43 | 95,661,783.43 |
| 一般风险准备 | 0 | 0 | - | 0 |
| 未分配利润 | 3,182,330,699.8 | 3,195,283,786.72 | 3,305,604,843.72 | 3,286,683,752.02 |
| 归属于母公司股东权益合计 | 5,368,713,903.59 | 5,382,066,407.24 | 5,492,769,753.69 | 5,474,102,359.07 |
| 少数股东权益 | 139,624,373.43 | 142,380,045.69 | 147,009,310.39 | 146,583,240.85 |
| 股东权益合计 | 5,508,338,277.02 | 5,524,446,452.93 | 5,639,779,064.08 | 5,620,685,599.92 |
| 负债和股东权益合计 | 7,652,079,297.02 | 7,605,976,333.4 | 7,429,579,726.43 | 7,230,360,796.53 |
| 公告日期 | 2025-10-29 | 2025-08-28 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |